Real-world Evidence (RWE) Solutions Market Worth $4.9 Billion by 2029
Dublin, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The "Real-world Evidence Solutions Market by Component, Application, End User - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The RWE solutions market is expected to grow at a CAGR of 11.8% from 2022 to 2029 to reach $4.9 billion by 2029
Rapidly growing big data in healthcare, shift from volume to value-based care, and rising focus towards personalized healthcare are the key factors driving the growth of the global RWE solutions market. Further, significant growth opportunities for existing market players and new entrants are provided by emerging markets, rising focus on end-to-end RWE services, and the rising adoption of wearable devices and AI in RWE.
An in-depth analysis of the geographical scenario of the RWE solutions market provides detailed qualitative and quantitative insights about the five major geographies (North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to command the largest share of the global RWE solutions market in 2022, followed by Asia-Pacific and Europe. However, Asia-Pacific is slated to register the fastest growth rate. The growth of this regional market is driven by the growing demand for data defining the value and effectiveness of medicines, the increasing need for conducting real-world studies in drug R&D, and the rising government initiatives for promoting the use of real-world studies for regulatory decision-making.
Scope of the Report
Global RWE Solutions Market, by Component
Datasets
Disparate Datasets
EMR/EHR/Clinical Data
Claims & Billing Data
Pharmacy Data
Product/Disease Registries Data
Other Disparate Datasets
Integrated Datasets
Consulting & Analytics
Global RWE Solutions Market, by Application
Market Access & Reimbursement/Coverage Decisions
Drug Development & Approvals
Oncology
Neurology
Immunology
Cardiovascular Diseases
Other Therapeutic Areas
Post Market Surveillance
Medical Device Development & Approvals
Other Applications
Global RWE Solutions Market, by End User
Pharmaceutical, Biotechnology, and Medical Device Companies
Healthcare Payers
Healthcare Providers
Other End Users
Global RWE Solutions Market, by Geography
Market Dynamics
Drivers
Rising Focus on Personalized Healthcare
Delays in Drug Development and the Consequent Increase in Development Costs
Growing Incidence of Chronic Diseases
Shift Toward Value-based Care
Rapidly Growing Big Data in the Healthcare Sector
Restraints
Reluctance to Rely on Real-World Studies
Opportunities
Emerging Economies
Rising Focus on end-to-end RWE Services
Challenges
Lack of Standardized Methodologies for Developing RWE
Trends
The Incorporation of Artificial Intelligence (AI) in the RWE Industry
The Adoption of AI Technologies is Growing in the Following Areas:
Clinical Trials Design
Modeling and Forecasting Patient Enrichment & Recruitment
Selecting Investigator Site
Patient Monitoring & Managing and Medication Adherence & Retention
AI-enabled Clinical Trial Analytics
Outsourcing Essential AI Solutions Via Strategic Partnerships & Collaborations
Market Access Using AI Solutions
Post-market Surveillance Using AI Solutions
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Insights
5. Real-world Evidence (RWE) Solutions Market: Regulatory Analysis
6. Pricing Models (Emr/Genomic/Integrated Datasets)
7. Real-world Evidence Solutions Market, by Component
8. Real-world Evidence Solutions Market, by Application
9. Real-world Evidence Solutions Market, by End User
10. Real-world Evidence Solutions Market, by Geography
11. Competitive Landscape
12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
13. Appendix
Companies Mentioned
Anthem Inc.
Clinigen Group plc
Cognizant Technology Solutions Corporation
IBM Corporation
ICON plc
IQVIA
Oracle Corporation
PAREXEL International Corporation
PerkinElmer Inc.
PPD Inc.
SAS Institute Inc.
UnitedHealth Group Incorporated
Flatiron Health
For more information about this report visit https://www.researchandmarkets.com/r/yrh8zy
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900